Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-041662
Filing Date
2016-11-10
Accepted
2016-11-10 08:02:29
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20160830_10q.htm 10-Q 579746
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15062
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 15045
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5682
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6029
  Complete submission text file 0001437749-16-041662.txt   2360945

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS snbp-20160930.xml EX-101.INS 304987
7 EXHIBIT 101.SCH snbp-20160930.xsd EX-101.SCH 28670
8 EXHIBIT 101.CAL snbp-20160930_cal.xml EX-101.CAL 23433
9 EXHIBIT 101.DEF snbp-20160930_def.xml EX-101.DEF 192618
10 EXHIBIT 101.LAB snbp-20160930_lab.xml EX-101.LAB 153856
11 EXHIBIT 101.PRE snbp-20160930_pre.xml EX-101.PRE 206684
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 161986050
SIC: 2834 Pharmaceutical Preparations